True North Dialysis Center, Llc is a medicare approved dialysis facility center in Floral Park, New York and it has 0 dialysis stations. It is located in Nassau county at 1 Cisney Ave, Floral Park, NY, 11001. You can reach out to the office of True North Dialysis Center, Llc at (516) 437-0789. This dialysis clinic is managed and/or owned by Davita. True North Dialysis Center, Llc has the following ownership type - Profit. It was first certified by medicare in March, 2017. The medicare id for this facility is 332750 and it accepts patients under medicare ESRD program.
Name | True North Dialysis Center, Llc |
---|---|
Location | 1 Cisney Ave, Floral Park, New York |
No. of Dialysis Stations | 0 |
Medicare ID | 332750 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
1 Cisney Ave, Floral Park, New York, 11001 | |
(516) 437-0789 | |
Not Available |
News Archive
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation (PE). These data were presented at the 2010 American Urological Association (AUA) Annual Meeting in San Francisco.
Rutgers researchers have found that a test widely used to diagnose whether children have autism is less reliable than previously assumed.
There is uncertainty about the best form of treatment for anorexia nervosa (AN). A report that is published in the current issue of Psychotherapy and Psychosomatics introduces a new treatment modality.
Nutrition researchers at Washington University School of Medicine in St. Louis have identified five common genetic variations that increase the risk of metabolic syndrome, a group of factors linked to heart disease and diabetes. Another variant they found appeared to protect against the condition.
› Verified 8 days ago
NPI Number | 1467905331 |
Organization Name | Floral Park Home Dialysis |
Doing Business As | True North Dialysis Center Llc |
Address | 1 Cisney Ave Floral Park, New York, 11001 |
Phone Number | (516) 437-0789 |
News Archive
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation (PE). These data were presented at the 2010 American Urological Association (AUA) Annual Meeting in San Francisco.
Rutgers researchers have found that a test widely used to diagnose whether children have autism is less reliable than previously assumed.
There is uncertainty about the best form of treatment for anorexia nervosa (AN). A report that is published in the current issue of Psychotherapy and Psychosomatics introduces a new treatment modality.
Nutrition researchers at Washington University School of Medicine in St. Louis have identified five common genetic variations that increase the risk of metabolic syndrome, a group of factors linked to heart disease and diabetes. Another variant they found appeared to protect against the condition.
› Verified 8 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular peritoneal dialysis at the center | 5 |
Adult patient months included in Kt/V greater than or equal to 1.7 | 13 |
Percentage of adult patients getting regular peritoneal dialysis at the center | |
Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation (PE). These data were presented at the 2010 American Urological Association (AUA) Annual Meeting in San Francisco.
Rutgers researchers have found that a test widely used to diagnose whether children have autism is less reliable than previously assumed.
There is uncertainty about the best form of treatment for anorexia nervosa (AN). A report that is published in the current issue of Psychotherapy and Psychosomatics introduces a new treatment modality.
Nutrition researchers at Washington University School of Medicine in St. Louis have identified five common genetic variations that increase the risk of metabolic syndrome, a group of factors linked to heart disease and diabetes. Another variant they found appeared to protect against the condition.
› Verified 8 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at True North Dialysis Center, Llc with elevated calcium levels.
Patients with hypercalcemia | 5 |
Hypercalcemia patient months | 13 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
Patients with Serumphosphor | 6 |
Patients with Serumphosphor less than 3.5 mg/dL | |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
Patients with Serumphosphor from 5.6 to 7 mg/dL | |
Patients with Serumphosphor greater than 7 mg/dL |
News Archive
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation (PE). These data were presented at the 2010 American Urological Association (AUA) Annual Meeting in San Francisco.
Rutgers researchers have found that a test widely used to diagnose whether children have autism is less reliable than previously assumed.
There is uncertainty about the best form of treatment for anorexia nervosa (AN). A report that is published in the current issue of Psychotherapy and Psychosomatics introduces a new treatment modality.
Nutrition researchers at Washington University School of Medicine in St. Louis have identified five common genetic variations that increase the risk of metabolic syndrome, a group of factors linked to heart disease and diabetes. Another variant they found appeared to protect against the condition.
› Verified 8 days ago